Mediclinic International PLC (LON:MDC)‘s stock had its “neutral” rating restated by equities researchers at Citigroup Inc. in a research report issued on Tuesday.

A number of other equities analysts have also commented on MDC. Investec lowered shares of Mediclinic International PLC to a “hold” rating and set a GBX 775 ($10.23) target price on the stock. in a research report on Monday, June 26th. Morgan Stanley lowered shares of Mediclinic International PLC to an “equal weight” rating and reduced their target price for the stock from GBX 825 ($10.89) to GBX 775 ($10.23) in a research report on Thursday, June 29th. Credit Suisse Group reaffirmed a “neutral” rating on shares of Mediclinic International PLC in a research report on Friday, July 21st. Jefferies Group LLC reduced their target price on shares of Mediclinic International PLC from GBX 650 ($8.58) to GBX 550 ($7.26) and set an “underperform” rating on the stock in a research report on Monday, September 25th. Finally, J P Morgan Chase & Co lowered shares of Mediclinic International PLC to a “neutral” rating and reduced their target price for the stock from GBX 898 ($11.85) to GBX 733 ($9.67) in a research report on Thursday, October 19th. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Mediclinic International PLC has a consensus rating of “Hold” and an average price target of GBX 740.89 ($9.78).

Shares of Mediclinic International PLC (MDC) opened at 616.00 on Tuesday. The company’s market capitalization is GBX 4.54 billion. Mediclinic International PLC has a 52-week low of GBX 616.00 and a 52-week high of GBX 941.50. The firm’s 50-day moving average price is GBX 684.15 and its 200 day moving average price is GBX 747.01.

COPYRIGHT VIOLATION NOTICE: “Citigroup Inc. Reiterates Neutral Rating for Mediclinic International PLC (MDC)” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/10/24/citigroup-inc-reiterates-neutral-rating-for-mediclinic-international-plc-mdc.html.

Mediclinic International PLC Company Profile

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.